KANEKA Your partner in the world of Chirality! Sl^|v"!*::v^
P?>?l
m\
.•«* «&
';3»
£*•
H or Bz (RandS)
•jfff' A n d T h e i r Derivatives
P^v-'*'•"'''''
KANEKA, a technologically versatile company, leading th< global chiral marketplace. Providing customers with solid foundations to support new product development from laboratory and pilot plant to full commercialization through process innovation.
"J 1
Technologies • Biotransformations, Biotechnologies • Organic chemistry Manufacturing From kg to 1,000's MT • Plants for bioprocesses and chemical reactions •Multi-purpose plants and dedicated plants • Penems & Carbapenems *ACE Inhibitor Intermediates > H M G Co. A Reductase Inhibitor Intermediates • Anti-AIDS Drugs Intermediates 1 D - A m i n o acids • C h i r a l Synthons Kaneka Corporation
Kaneka America Corporation
Kaneka Pharma Europe N.V. Triomflaan 173
Fine Chemicals Division
Pharmaceuticals Division
3-2-4. Nakanoshima Kita-Ku
65 East 55th Street
I 160 Brussel, Belgium
Osaka 530-8288, Japan
New York, N.Y. 10022
Tel:
02-663-0340
Tel:
06-226-5142
Tel:
212-705-4340
Fax:
02-663-0361
Fax:
06-226-5128
Fax:
212-705-4350
[email protected] [email protected] [email protected] www.kaneka.co.jp/finechem/ © Kaneka Corporation
CIRCLE 6 1 ON READER SERVICE CARD
mi
Quality Assurance • GMP •Many DMPs filed • Producing pharmaceutical bulk & intermediates
KaneKa
